STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as the reference product, STEQEYMA will be priced with a wholesale acquisition cost (WAC) list price at […]
Tag: Medical Pharmaceuticals
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy
YONGIN, South Korea, March 12, 2025 /PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 […]
Psoriatic Arthritis Market Sees Major Shift with Growing Biosimilar Adoption
The arrival of biosimilars like Celltrion’s STEQEYMA and Biocon’s YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As competition intensifies, these biosimilars are reshaping treatment choices and driving a […]
ROZLYTREK’s Market Growth Reflects Transforming Treatment for NTRK and ROS1-Positive Cancers
As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors, such as larotrectinib (VITRAKVI), may influence growth, its ability […]
Leading Experts at Premier Plastic Surgery Partners Share Insights on Rapid Recovery & Remarkable Results
Facial plastic surgeons with the nation’s first physician-led plastic surgery platform explain why facelift procedures are more popular than ever and how advancements in technique are delivering better, more natural results. BOSTON, March 12, 2025 […]
